Cas:65310-45-4 12-Chlorodehydroabietic acid manufacturer & supplier

We serve Chemical Name:12-Chlorodehydroabietic acid CAS:65310-45-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

12-Chlorodehydroabietic acid

Chemical Name:12-Chlorodehydroabietic acid
CAS.NO:65310-45-4
Synonyms:5,12-Naphthacenedione,11-chloro-2,6-dihydroxy;12-chlorodehydroabietic acid;12-chloro-5,9-dihydroxynaphthacene-6,11-dione
Molecular Formula:C20H27ClO2
Molecular Weight:334.88000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:445.4ºC at 760 mmHg
Density:1.132g/cm3
Index of Refraction:1.548
PSA:37.30000
Exact Mass:334.17000
LogP:5.55830

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5,12-Naphthacenedione,11-chloro-2,6-dihydroxy chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,12-chloro-5,9-dihydroxynaphthacene-6,11-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5,12-Naphthacenedione,11-chloro-2,6-dihydroxy Use and application,5,12-Naphthacenedione,11-chloro-2,6-dihydroxy technical grade,usp/ep/jp grade.


Related News: By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. 12-Chlorodehydroabietic acid manufacturer Active pharmaceutical ingredients directly impact disease. 12-Chlorodehydroabietic acid supplier After testing, our quality assurance staff confirms that everything has been performed correctly in accordance with GMP from manufacturing of API to quality testing. 12-Chlorodehydroabietic acid vendor In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. 12-Chlorodehydroabietic acid factory Health Canada said it was planning an onsite inspection this summer and that it would not accept any product or ingredients made at the plant until the inspection was complete.